Sirolimus for patients with progressive epithelioid hemangioendothelioma.
![Thumbnail](/bitstream/handle/internal/4335/cncr.33246.pdf.jpg?sequence=6&isAllowed=y)
View/ Open
Date
2020-10-27ICR Author
Author
Smrke, AM
Huang, PH
Jones, RL
Type
Journal Article
Metadata
Show full item recordAbstract
Epithelioid hemangioendothelioma is an ultrarare soft tissue sarcoma with limited literature to guide treatment. The results from a robust retrospective cohort study support the use of sirolimus for patients who have multifocal epithelioid hemangioendothelioma without serosal effusion.
Collections
Research team
Molecular and Systems Oncology
Molecular and Systems Oncology
Language
eng
Date accepted
2020-09-12
License start date
2020-10-27
Citation
Cancer, 2020
Publisher
WILEY